These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24273035)

  • 1. Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia.
    Mai KT; Ball CG; Kos Z; Belanger EC; Islam S; Sekhon H
    Diagn Cytopathol; 2014 Jul; 42(7):555-63. PubMed ID: 24273035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
    Jackson J; Barkan GA; Kapur U; Wojcik EM
    Cancer Cytopathol; 2013 Jul; 121(7):398-402. PubMed ID: 23364860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens.
    McCroskey Z; Pambuccian SE; Kleitherms S; Antic T; Cohen MB; Barkan GA; Wojcik EM
    Am J Clin Pathol; 2015 Dec; 144(6):902-8. PubMed ID: 26572997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
    Garbar C; Mascaux C; Wespes E
    Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a consistent cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytologic specimens possible? A comparison between cytomorphologic features of low-grade urothelial carcinoma and non-neoplastic changes shows extensive overlap, making a reliable diagnosis impossible.
    McCroskey Z; Kliethermes S; Bahar B; Barkan GA; Pambuccian SE; Wojcik EM
    J Am Soc Cytopathol; 2015; 4(2):90-97. PubMed ID: 31051715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma.
    Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S
    Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep.
    Xin W; Raab SS; Michael CW
    Diagn Cytopathol; 2003 Sep; 29(3):125-9. PubMed ID: 12951678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis.
    Cakir E; Kucuk U; Pala EE; Sezer O; Ekin RG; Cakmak O
    APMIS; 2017 May; 125(5):431-436. PubMed ID: 28225151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR; Humphrey PA
    Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
    Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
    Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.
    Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J
    Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?
    Guy L; Savareux L; Molinié V; Botto H; Boiteux JP; Lebret T
    Eur Urol; 2006 Sep; 50(3):516-20; discussion 520. PubMed ID: 16632184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
    Alhamar M; Al-Ahmadie HA; Feratovic R; Lin O
    Cancer Cytopathol; 2024 Mar; 132(3):144-151. PubMed ID: 38054371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.